Virtual Clinical Trials Global Market Report 2026

Virtual clinical trials, also known as remote or decentralized clinical trials, involve the integration of digital health technologies to enable remote participation beyond the traditional clinical trial sites. Utilizing tools such as tablets, smartphone apps, or wearable sensors, these trials bring about a significant shift in clinical research methodology, creating a more patient-centric ecosystem.

The primary design types of virtual clinical trials comprise observational trials, interventional trials, and expanded access trials. Observational trials specifically pertain to solutions and services used in this context. Observational studies aim to understand what happens to individuals in various scenarios, with the study team observing participants without directly influencing the treatments they receive. Virtual clinical trials find application across different phases, including Phase I, Phase II, Phase III, and Phase IV. They are employed in clinical trials focused on drugs and devices used in the treatment of various medical conditions such as CNS disorders, autoimmune/inflammatory diseases, cardiovascular diseases, metabolic/endocrinology disorders, infectious diseases, oncology, genitourinary conditions, ophthalmology, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the virtual clinical trials market by increasing costs associated with importing digital health devices, wearable technologies, and advanced IT infrastructure required to support decentralized trial platforms. Regions such as North America, Europe, and Asia Pacific experience higher setup and operational costs, particularly affecting remote monitoring technologies, data platforms, and cloud deployment segments. However, tariffs are also encouraging regional production of digital health tools, development of localized platforms, and investments in domestic healthcare technology ecosystems. This dual effect raises cost pressures while also driving innovation and self sufficiency in virtual clinical trial capabilities.

The virtual clinical trials market research report is one of a series of new reports from The Business Research Company that provides virtual clinical trials market statistics, including virtual clinical trials industry global market size, regional shares, competitors with a virtual clinical trials market share, detailed virtual clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the virtual clinical trials industry. This virtual clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The virtual clinical trials market size has grown rapidly in recent years. It will grow from $12.95 billion in 2025 to $14.36 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to rising need for faster drug development, challenges in traditional clinical trial participation, increasing technology adoption in healthcare research, regulatory support for decentralized models, rising patient engagement initiatives.

The virtual clinical trials market size is expected to see rapid growth in the next few years. It will grow to $21.58 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to growing demand for remote healthcare solutions, expansion of precision medicine trials, increasing use of digital patient monitoring tools, rising investment in digital clinical infrastructure, continuous innovation in decentralized trial technologies. Major trends in the forecast period include growing adoption of remote clinical trial participation, increasing use of wearables and connected health devices, rising shift toward patient centric clinical research models, growing utilization of digital platforms for clinical monitoring, increasing focus on reducing site based clinical dependencies.

The rising number of clinical trials is expected to drive the growth of the virtual clinical trials market in the coming years. Clinical trials are research studies carried out on human participants to assess the safety, effectiveness, and potential benefits of new medical treatments, interventions, or drugs. The increase in clinical trials has created opportunities for the expansion and advancement of virtual clinical trials, which provide a more efficient, cost-effective, and patient-centric approach to conducting clinical research. For example, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, the number of pharmaceutical industry trials initiated in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, the growing number of clinical trials is driving the expansion of the virtual clinical trials market during the forecast period.

Major companies operating in the virtual clinical trials market are focusing on developing advanced solutions, such as no-code digital trial platforms, to streamline complex clinical workflows. No-code digital solutions enable users to design, configure, and deploy clinical trial components without requiring deep technical expertise, reducing development time, improving accuracy, and enhancing operational efficiency. For instance, in August 2024, Medable Inc., a US-based clinical trial technology company, launched Medable Studio as part of its digital trial platform. This solution allows sponsors to build, translate, validate, and launch eCOA, eConsent, Televisit, and sensor-based workflows through an intuitive point-and-click interface, replacing traditional manual and service-heavy configuration processes. It provides real-time visibility into study content, scheduling, translations, and user flows, while enabling teams to customize protocol-specific designs without lengthy professional service cycles. Integrated with Medable's broader digital trial ecosystem, the platform accelerates study start-up, improves operational control, and reduces trial timelines and costs.

In February 2024, PCM Trials, a home health care service based in the U.S., acquired EmVenio Research Inc. for an undisclosed amount. This acquisition is intended to enhance both PCM Trials' and EmVenio's capabilities in recruiting and retaining diverse populations for clinical research, which is essential for regulatory approval. The partnership gives PCM Trials access to EmVenio's site network that targets underserved communities, promoting patient-centric clinical trials and improving retention and diversity. EmVenio Research Inc. is a U.S.-based company dedicated to enabling virtual clinical trials through advanced technology and data analytics to create more efficient research processes.

Major companies operating in the virtual clinical trials market report are ICON plc, Parexel International Pvt. Ltd., IQVIA Holdings Inc., Covance Research Products Inc., Pharmaceutical Research Associates Inc., Medidata Solution Inc., Oracle Corporation, Clario Tech Ltd., Medable Inc., Science 37 Holdings Inc., THREAD Research, Clinical Ink Inc., Veeva Systems Inc., Clinerion Ltd., CRF Health Group Limited, Crio Inc., Deep Lens Inc., Florence Healthcare Inc., goBalto Inc., Medrio Inc., Mint Medical Ltd., Mytrus Inc., OpenClinica LLC, PatientWing, RealTime-CTMS LLC, Reify Health, Sanguine Biosciences Inc., TriNetX Inc., VirTrial LLC

North America was the largest region in the virtual clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the virtual clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The virtual clinical trials market includes revenues earned by entities by providing services such as pilot studies and feasibility studies, prevention trials, screening trials, treatment trials, multi-arm multi-stage (mams) trials, cohort studies, case control studies, and cross sectional studies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Virtual Clinical Trials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses virtual clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for virtual clinical trials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The virtual clinical trials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Design: Observational Trials; Interventional Trials; Expanded Access Trials
• 2) By Phases: Phase II; Phase III; Phase IV
• 3) By Indication: CNS; Autoimmune Or Inflammation; Cardiovascular Disease; Metabolic Or Endocrinology; Infectious Disease; Oncology; Genitourinary; Ophthalmology; Other Indications
• Subsegments:
• 1) By Observational Trials: Prospective Cohort Studies; Retrospective Studies; Case-Control Studies
• 2) By Interventional Trials: Randomized Controlled Trials (RCTs); Non-Randomized Trials; Adaptive Trials
• 3) By Expanded Access Trials: Single-Patient Expanded Access; Multi-Patient Expanded Access; Compassionate Use Programs
• Companies Mentioned: ICON plc; Parexel International Pvt. Ltd.; IQVIA Holdings Inc.; Covance Research Products Inc.; Pharmaceutical Research Associates Inc.; Medidata Solution Inc.; Oracle Corporation; Clario Tech Ltd.; Medable Inc.; Science 37 Holdings Inc.; THREAD Research; Clinical Ink Inc.; Veeva Systems Inc.; Clinerion Ltd.; CRF Health Group Limited; Crio Inc.; Deep Lens Inc.; Florence Healthcare Inc.; goBalto Inc.; Medrio Inc.; Mint Medical Ltd.; Mytrus Inc.; OpenClinica LLC; PatientWing; RealTime-CTMS LLC; Reify Health; Sanguine Biosciences Inc.; TriNetX Inc.; VirTrial LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.